Capillary Technologies India share price today

Capillary Technologies India Ltd's share price was ₹507.80 at the close on 6 November 2026. It has been falling for 36 weeks. That is 5.9% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹449 and ₹732, and at that close it sat 21% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Capillary Technologies India Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 1 week running.

Over the last 1 year the share price moved −16% while the NIFTY 500 moved −9%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 30 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: promoters cut their stake for 3 quarters in a row, indian funds and insurers (DIIs) raised their stake for 3 quarters in a row and foreign funds (FIIs) cut their stake for 3 quarters in a row.

1. Promoters cut their stake for 3 quarters in a row

   From 52.3% to 47.2% of the company by the September 2026 quarter.

2. Indian funds and insurers (DIIs) raised their stake for 3 quarters in a row

   From 17.8% to 21.9% of the company by the September 2026 quarter.

3. Foreign funds (FIIs) cut their stake for 3 quarters in a row

   From 3.9% to 2.6% of the company by the September 2026 quarter.

For April to June 2026 (the quarter ended 30 June 2026), Capillary Technologies India reported revenue of ₹257 crore, up 42.7% from ₹180 crore a year earlier, and a loss of ₹9.55 crore, down 1,373.3% from ₹0.75 crore.

Capillary Technologies India results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Capillary Technologies India's management discussed these results on a call held on 4 August 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Capillary Technologies India closed at ₹507.80 on 6 November 2026, down 16.3% from ₹606.50 a year earlier (21 November 2025). Its highest weekly close since November 2025 was ₹719.35 on 12 December 2025.

Capillary Technologies India share price: then and now

Weekly closing prices. Each change is the move from that price to the 6 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

54 weekly closes from 21 November 2025 to 6 November 2026.

6 Nov 2026: Capillary Technologies India closed at ₹507.80, up 1.0% on the week and down 10.4% on the month. 4 Aug 2026: Capillary Technologies India held its results call for April to June 2026. Management guided: FY27 revenue above ₹1,065 crore.

Earlier

• Results for April to June 2026: Revenue up 42.7% and profit down 1,373.3% on a year earlier.

Capillary Technologies India has paid no dividend on the NSE since its first NSE close in our records (21 November 2025), the start of the period we checked.

No. Capillary Technologies India Ltd paid out 0% of its profit as dividends in each of its last 6 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate.

From the NSE corporate-actions record, read 7 November 2026.

On the call for April to June 2026, held on 4 August 2026, Capillary Technologies India's management guided: FY27 revenue above ₹1,065 crore.

“My expectation is that the journey will be from approximately breakeven today to approximately 15% margin in a year. Over the following year, we will reach a 35-40% margin. - Aneesh Reddy Boddu”Founder, Managing Director & CEO, on the call for April to June 2026

What management guided

• FY27 operating profit above ₹172 crore.
• FY27 organic revenue growth approximately 17% and consolidated growth approximately 23% including currency; new ACV at least 30-40% higher on a year earlier.
• AiRA to reach 5-10% of revenue this year.
• SessionM payback possibly within FY27; server-cost savings of $6-8 million over 3-4 quarters; operating margin approximately 15% in one year and 35-40% the following year.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 4 August 2026.

When Capillary Technologies India reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Kognitiv's first customer migration in September - check AI-tool validation and subsequent rollout pace.

Capillary Technologies India is on one of our India lists: IT stocks.

Capillary Technologies India Ltd posted a net loss of ₹9.6 Cr in the Jun 2026 quarter. Full-year FY26 profit was ₹52.0 Cr. That loss is 3.7% of the quarter's revenue. The same quarter a year earlier earned ₹0.8 Cr. 1 of the last 8 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

Jun 2026 profit was −₹9.6 Cr, −1,373.3% on a year earlier. For the full year, FY26 profit was ₹52.0 Cr (+300.0% on the year before).

Why profit moved: revenue changed +42.7% on a year earlier and the margin moved +5.8 percentage points. Most of the change came from keeping more of each sale.

On average over the last four quarters, profit changed −351.6% and revenue +28.1%. Profit is growing slower than sales: rising costs are taking part of the growth.

Capillary Technologies India Ltd reported ₹257 Cr of revenue in the Jun 2026 quarter, +42.7% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. Over 5 years it has grown 33.9% a year on average. The last full year, FY26, came in at ₹735 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹811 Cr.

FY26 revenue was ₹735 Cr, +22.9% on the year before.

Recent pace: the last four quarters grew +28.1% on average, against 33.9% a year over the longer run, so this year is growing slower than its own long-run rate.

Capillary Technologies India Ltd's operating margin was 15.7% in the Jun 2026 quarter, 5.8 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 6 years it has been between −23.0% and 13.0%. The latest quarter is above every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +5.8 percentage points on the year while gross margin changed +0.0 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

As noted under valuation: when margins are at a record, every ratio built on profit looks better than usual, so a low multiple can mislead.

Over the last 2 years, 160% of Capillary Technologies India Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹150 Cr of operating cash against ₹52.0 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹234 Cr of spending on assets, free cash was −₹84.0 Cr: it spent more than its operations brought in.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 160% of profit came in as cash: the cash cycle got 27 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner.

What to look at next: the bigger use of cash is spending on new assets, at 2.3× depreciation over three years. The next section checks what that spending is building.

Capillary Technologies India Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 90 days in FY26, down from 117 days in FY21. It spent ₹442 Cr on assets over the last 3 years.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹735 Cr, each day of that cycle ties up about ₹2.0 Cr, so roughly ₹181 Cr is tied up in the business at any time.

Spending on assets: ₹442 Cr over the last 3 years, against ₹191 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Capillary Technologies India Ltd's P/E is 78.8×, near the low end of its own history: it has been lower only 9% of the time. Its usual P/E (the middle reading) is 732.0×, over 11 months of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹5.31.

Keep one thing in mind: margins are the best this company has ever reported. A multiple that looks low against its own past can mislead when profit is at a record. If margins fall back, today's multiple is higher than it looks.

Why the multiple is where it is: over the past year earnings per share moved +264.6% while the price moved −16.3%. Earnings did better than the price, which pulled the multiple down within its own range.

In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple.

Capillary Technologies India Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: with too little history, we say so rather than guess a direction.

One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.

There are fewer than eight usable quarters, so this page does not guess a direction from so little history.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Capillary Technologies India Ltd earned a ROCE of 3% in FY26. That is up from a low of −68% in FY22. Its return on capital used (ROIC) is 7.3 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses.

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

It comes from a 7.1% net margin and 0.57× asset turnover (sales divided by assets).

Why the return is what it is (FY26): a 7.1% net margin × 0.57× asset turnover × 1.27× leverage (assets divided by equity) ≈ 5.1% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.

The key test, return on capital used minus the cost of capital: 4.7% − 12.0% = −7.3 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

Capillary Technologies India Ltd has total debt of ₹54.0 Cr against shareholder equity of ₹1,059 Cr as of Sep 2026, so its debt is 0.05× its equity, which is very little. Year by year, that ratio went from 0.19 in FY25 to 0.05 in FY26. So the returns on this page come from the business, not from borrowed money.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

No group of Capillary Technologies India Ltd's owners changed its stake by a full percentage point over the last 4 quarters. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

For Capillary Technologies India Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

46.8 out of 100, rank 43 of 69 in IT - Software, with 63% of the evidence available.

Capillary Technologies India Ltd scores 46.8 out of 100 against the 69 companies it is compared with in IT - Software, ranking 43. There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone.

The three scored parts add up to the total exactly: 30.1 + 5.7 + 11 = 46.8 (no relative-strength reading this week; its 20 points are shared across the other three). This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Capillary Technologies India ranks 43 of 69 IT - Software companies on the 4-Factor Sector Score, with 46.8 out of 100.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: IT - Software, all 69 compared on one page.

Capillary Technologies India is the 21st largest of 68 IT - Software companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Mastek, 63 Moons Technologies and Datamatics Global Services. Just below it: Cigniti Technologies, R Systems International and Aurionpro Solutions.

IT - Software companies close in size

18. Mastek Ltd ₹4,433 crore
19. 63 Moons Technologies Ltd ₹4,390 crore
20. Datamatics Global Services Ltd ₹4,163 crore
21. Capillary Technologies India Ltd ₹4,000 crore
22. Cigniti Technologies Ltd ₹3,472 crore
23. R Systems International Ltd ₹3,192 crore
24. Aurionpro Solutions Ltd ₹2,986 crore

All 68 IT - Software companies, largest first

Companies close in size in other industries

937. Purple Style Labs Ltd ₹4,011 crore
938. Shoppers Stop Ltd ₹4,008 crore · Retail - Departmental Stores
939. Capillary Technologies India Ltd ₹4,000 crore
940. Gujarat Alkalies & Chemicals Ltd ₹3,975 crore · Chemicals - Inorganic - Caustic Soda/Soda Ash
941. MPS Ltd ₹3,970 crore · E-Commerce - Platform - Utility

Sector Alpha, written by code from the published numbers. Data as of 6 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.